Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US2561352038

SecurityRDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
InstitutionAssetmark, Inc
Latest Disclosed Ownership21,145 shares
Latest Disclosed Value $ 292,858
Assetmark, Inc reports 11.85% increase in ownership of RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)

On May 6, 2026 - Assetmark, Inc filed a 13F-HR form disclosing ownership of 21,145 shares of Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock) (US:RDY) valued at $292,858 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 18,905 shares of Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock). This represents a change in shares of 11.85% during the quarter. The current value of the position is $275,308 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F DR REDDYS LABS ADR 256135203 21,145 2,240 11.85 293 10.19 0.0006
2026-01-23 2025-12-31 13F DR REDDYS LABS ADR 256135203 18,905 -932 -4.70 265 -4.33 0.0005
2025-11-06 2025-09-30 13F DR REDDYS LABS ADR 256135203 19,837 988 5.24 277 -2.12 0.0006
2025-08-04 2025-06-30 13F DR REDDYS LABS ADR 256135203 18,849 -182,748 -90.65 283 -89.36 0.0007
2025-05-06 2025-03-31 13F DR REDDYS LABS ADR 256135203 201,597 -3,118 -1.52 2,659 -17.73 0.0073
2025-02-06 2024-12-31 13F DR REDDYS LABS ADR 256135203 204,715 167,049 443.50 3,232 8.02 0.0088
2024-11-01 2024-09-30 13F DR REDDYS LABS ADR 256135203 37,666 2,836 8.14 2,993 12.78 0.0086
2024-08-13 2024-06-30 13F DR REDDYS LABS ADR 256135203 34,830 -14,540 -29.45 2,654 -26.73 0.0082
2024-05-07 2024-03-31 13F DR REDDYS LABS ADR 256135203 49,370 1,659 3.48 3,621 9.10 0.0118
2024-02-09 2023-12-31 13F DR REDDYS LABS ADR 256135203 47,711 1,479 3.20 3,320 7.38 0.0120
2023-10-27 2023-09-30 13F DR REDDYS LABS ADR 256135203 46,232 45,096 3,969.72 3,092 4,253.52 0.0124
2023-08-11 2023-06-30 13F DR REDDYS LABS LTD ADR ADR 256135203 1,136 -2,259 -66.54 72 -63.21 0.0003
2023-05-05 2023-03-31 13F DR REDDYS LABS LTD ADR ADR 256135203 3,395 2,664 364.43 193 421.62 0.0008
2023-02-10 2022-12-31 13F DR REDDYS LABS ADR 256135203 731 -76 -9.42 38 -11.90 0.0002
2022-11-01 2022-09-30 13F DR REDDYS LABS ADR 256135203 807 58 7.74 42 2.44 0.0002
2022-08-03 2022-06-30 13F DR REDDYS LABS LTD ADR ADR 256135203 749 -174 -18.85 41 -19.61 0.0002
2022-05-13 2022-03-31 13F DR REDDYS LABS LTD ADR ADR 256135203 923 274 42.22 51 21.43 0.0002
2022-02-14 2021-12-31 13F DR REDDYS LABS LTD ADR ADR 256135203 649 463 248.92 42 250.00 0.0002
2021-11-12 2021-09-30 13F DR REDDYS LABS LTD ADR ADR 256135203 186 -19,829 -99.07 12 -99.18 0.0001
2021-08-16 2021-06-30 13F DR REDDYS LABS LTD ADR ADR 256135203 20,015 2,486 14.18 1,471 36.71 0.0068
2021-05-14 2021-03-31 13F DR REDDYS LABS ADR 256135203 17,529 3,106 21.54 1,076 4.67 0.0055
2021-02-10 2020-12-31 13F DR REDDYS LABS LTD ADR ADR 256135203 14,423 6,170 74.76 1,028 79.09 0.0057
2020-11-13 2020-09-30 13F DR REDDYS LABS LTD ADR ADR 256135203 8,253 5,105 162.17 574 243.71 0.0037
2020-08-11 2020-06-30 13F DR REDDYS LABS LTD ADR ADR 256135203 3,148 946 42.96 167 87.64 0.0012
2020-05-12 2020-03-31 13F DR REDDYS LABS LTD ADR ADR 256135203 2,202 703 46.90 89 45.90 0.0008
2020-02-11 2019-12-31 13F DR REDDYS LABS LTD ADR ADR 256135203 1,499 1,386 1,226.55 61 1,425.00 0.0005
2019-11-13 2019-09-30 13F DR REDDYS LABS LTD ADR ADR 256135203 113 113 4 0.0000
2017-09-15 2017-03-31 13F/A-1 DR REDDYS LABS LTD ADR ADR 256135203 0 -4 -100.00 0 0.0000
2017-09-15 2016-12-31 13F/A-1 DR REDDYS LABS LTD ADR ADR 256135203 4 4 0 0.0000
2017-02-14 2016-12-31 13F DR REDDYS LABS LTD ADR ADR 256135203 4 4 0
2017-09-14 2016-03-31 13F/A-1 DR REDDYS LABS LTD ADR SPONSORED ADR 256135203 0 -23 -100.00 0 -100.00
2017-09-14 2015-12-31 13F/A-1 DR REDDYS LABS LTD ADR SPONSORED ADR 256135203 23 23 1 0.0000
2016-02-12 2015-12-31 13F DR REDDYS LABS LTD ADR SPONSORED ADR 256135203 23 23 1
2015-11-10 2015-09-30 13F DR REDDYS LABS LTD ADR SPONSORED ADR 256135203 0 0 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.